Eleftherios Diamandis
Born
Eleftherios Phedias Diamandis

(1952-10-08) October 8, 1952
Limassol, Cyprus
CitizenshipCanada
Cyprus
EducationUniversity of Athens
University of Toronto
Known forResearch on cancer biomarkers
SpouseAnastasia
Children2
Scientific career
FieldsClinical chemistry
InstitutionsUniversity of Toronto

Eleftherios Phedias Diamandis FRCPC FRSC (born October 8, 1952)[1] is a Greek Cypriot-Canadian biochemist who specializes in clinical chemistry. He is Professor & Head of Clinical Biochemistry in the Department of Laboratory Medicine and Pathobiology at the University of Toronto in Toronto, Ontario, Canada. He is also Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network, both of which are also located in Toronto.[2]

Honors and awards

Diamandis is a member of the Academy of Athens and the Royal Society of Canada. He is also a fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, and the Royal College of Physicians and Surgeons of Canada. From the American Association for Clinical Chemistry, he has received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, among other awards; he is also a member of the Association's Hall of Fame.[2][3]

Theranos

In May 2015, Diamandis performed a deep investigation into claims of health technology company Theranos and concluded in a report that "most of the company's claims are exaggerated."[4][5] This insight from Diamandis triggered John Carreyrou to further investigate the claims that had been made by Theranos. At the time, Theranos was widely considered a reliable and functional analysis company.[4]

References

  1. ↑ "Eleftherios P. Diamandis CV" (PDF). University of Toronto. 2017-04-28. Retrieved 2019-03-26.
  2. 1 2 "Eleftherios Diamandis". University of Toronto. Archived from the original on 2019-03-26. Retrieved 2019-03-26.
  3. ↑ "Eleftherios P. Diamandis, MD, PhD". Hall of Fame. American Association for Clinical Chemistry. Retrieved 2019-03-26.
  4. 1 2 Diamandis, E. P. (2015). "Theranos phenomenon: promises and fallacies". Clinical Chemistry and Laboratory Medicine. 53 (7): 989–993. doi:10.1515/cclm-2015-0356. PMID 26030792. S2CID 13822780.
  5. ↑ Friedman, Lauren F.; Loria, Kevin. "A scientist just raised 4 serious questions about the blood test that made Elizabeth Holmes a billionaire". Business Insider. Retrieved June 26, 2015.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.